Efficient Photosensitizer Delivery by Neutrophils for Targeted Photodynamic Therapy of Glioblastoma
Pharmaceuticals · 19.02.2025 · 18 (2) · 276
DOI: 10.3390/ph18020276 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pharmaceuticals, online erschienen am 19.02.2025. Verfasst von Ruojian Wen und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Physiology, School of Medicine, Jianghan University, Wuhan 430056, China. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: The National Natural Science Foundation of China.
Abstract (Originalsprache)
Background/Objectives: Glioblastoma (GBM) is the deadliest type of brain tumor and photodynamic therapy (PDT) is a promising treatment modality of GBM. However, insufficient photosensitizer distribution in the GBM critically limits the success of PDT. To address this obstacle, we propose tumoritropic neutrophils (NE) as active carriers for photosensitizer delivery to achieve GBM-targeted PDT.
Methods
Isolated mouse NE were loaded with functionalized hexagonal boron nitride nanoparticles carrying the photosensitizer chlorin e6 (BNPD-Ce6). In vitro experiments were conducted to determine drug release from the loaded NE (BNPD-Ce6@NE) to mouse GBM cells and consequential photo-cytotoxicity. In vivo experiments were performed on mice bearing intracranial graft GBMs to demonstrate GBM-targeted drug delivery and the efficacy of anti-GBM PDT mediated by BNPD-Ce6@NE.
Results
BNPD-Ce6@NE displayed good viability and migration ability, and rapidly released BNPD-Ce6 to co-cultured mouse GBM cells, which then exhibited marked reactive oxygen species (ROS) generation and cytotoxicity following 808 nm laser irradiation (LI). In the in vivo study, a single intravenous bolus injection of BNPD-Ce6@NE resulted in pronounced Ce6 distribution in intracranial graft GBMs 4 h post injection, which peaked around 8 h post injection. A PDT regimen consisting of multiple intravenous BNPD-Ce6@NE injections each followed by one extracranial tumor-directed LI 8 h post injection significantly slowed the growth of intracranial graft GBMs and markedly improved the survival of host animals. Histological analysis revealed massive tumor cell damage and NE infiltration in the PDT-treated GBMs.
Conclusions
NE are efficient carriers for GBM-targeted photosensitizer delivery to achieve efficacious anti-GBM PDT.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Physiology, School of Medicine, Jianghan University, Wuhan 430056, China.
- Department of Anatomy, School of Medicine, Jianghan University, Wuhan 430056, China.
- Institute of Biomedical Sciences, School of Medicine, Jianghan University, Wuhan 430056, China.
- Institute of Ophthalmological Research, Department of Ophthalmology, Renmin Hospital of Wuhan University, Wuhan 430060, China.
- Department of Pharmacology, School of Basic Medical Sciences, Wuhan University, Wuhan 430072, China.
ORCID-Profile: Ruojian Wen
Förderung
- The National Natural Science Foundation of China
Zitieren
APA
Wen, R., Liu, Y., Tian, X., Xu, Y., & Chen, X. (2025). Efficient Photosensitizer Delivery by Neutrophils for Targeted Photodynamic Therapy of Glioblastoma. Pharmaceuticals, 18(2), 276. https://doi.org/10.3390/ph18020276
Vancouver
Wen R, Liu Y, Tian X, Xu Y, Chen X. Efficient Photosensitizer Delivery by Neutrophils for Targeted Photodynamic Therapy of Glioblastoma. Pharmaceuticals. 2025;18(2):276. doi:10.3390/ph18020276
BibTeX
@article{Wen2025,
author = {Wen, Ruojian and Liu, Yuwei and Tian, Xiang and Xu, Yonghong and Chen, Xiao},
title = {Efficient Photosensitizer Delivery by Neutrophils for Targeted Photodynamic Therapy of Glioblastoma},
journal = {Pharmaceuticals},
year = {2025},
volume = {18},
number = {2},
pages = {276},
doi = {10.3390/ph18020276}
}
EUVIMED